Price & Technical Structure
- Short-term returns have been positive over the last 1 month (+17.4%) and 3 months (+11.9%).
- The stock is in a bullish trend, trading above its 9, 21, and 50-day EMAs, with a trend alignment score of 3.
- Momentum is strong, indicated by an RSI of 69.67 and a bullish MACD crossover.
- The price is trading near the upper Bollinger Band (99.49% of the way) and has a 1-year RSI percentile of 98.71, suggesting overbought conditions.
- The stock is trading 15.98% below its 52-week high and 17.38% above its 52-week low, with a current drawdown of -15.98%.
The stock exhibits a strong bullish trend, supported by its positioning above key EMAs and a positive trend alignment score. Momentum indicators like RSI and MACD also signal strength. However, the price is trading very close to the upper Bollinger Band and shows a high RSI percentile, indicating potential overbought conditions. Structurally, the stock has recovered significantly from its 52-week low but remains below its 52-week high. Volume conviction is not explicitly strong based on the provided data.
Weekly Momentum
- The stock rose 8.16% this week, marking the third consecutive week of gains, driven by positive analyst sentiment and strong technical indicators.
- Technical indicators show strong bullish momentum, with RSI at 70.4 (overbought) and a positive MACD histogram, despite a mixed trend in moving averages.
- The company reported positive Q4 FY26 results with revenue up 10% YoY and net profit up 7.2% YoY, alongside strategic expansion plans.
- Max Healthcare shares jumped over 6% on June 18 after Citi reiterated a buy rating, contributing to the week's positive price action.
- The company's management actively engaged with investors through various conferences and meetings throughout May and June 2026.
Max Healthcare is experiencing a strong positive momentum this week, reflected in its significant stock price increase and bullish technical indicators. Recent financial results show continued growth, and active investor engagement through conferences suggests management confidence. The stock is trading above key moving averages, indicating a healthy short-to-medium term trend, although the RSI suggests it is currently in overbought territory.
Quarterly Analysis
Max Healthcare Institute Ltd reported a solid quarter with revenue increasing 12% year-over-year to ₹2,143 Crores, indicating strong top-line growth.
Net Profit rose 7% year-over-year to ₹342 Crores, showing improved profitability despite rising expenses.
Revenue from operations increased by 4% quarter-over-quarter, demonstrating positive recent momentum.
Net Profit also saw a 14% increase quarter-over-quarter, reflecting strong sequential performance.
Tax Expense saw a significant increase of 46% year-over-year, reaching ₹122 Crores, which warrants attention.
Total Expenses increased 11% year-over-year to ₹1,726 Crores, indicating rising operational costs.
The company achieved solid revenue growth and improved net profit, but this was accompanied by significant increases in expenses and tax, indicating margin pressure despite top-line expansion.
Max Healthcare Institute Ltd demonstrated robust revenue growth, with Revenue from operations reaching ₹2,143 Crores for the quarter ended March 31, 2026. This represents a 12% increase compared to the same quarter last year, signifying sustained growth in business activity. Sequentially, Revenue increased by 4% from ₹2,068 Crores in the previous quarter, indicating positive recent momentum.
Despite revenue growth, the company experienced increased expenses and tax, impacting overall profitability trends. Total Expenses for the quarter were ₹1,726 Crores, an increase of 11% compared to the same quarter last year. This rise in expenses, alongside a 46% year-over-year increase in Tax Expense to ₹122 Crores, suggests cost pressures are affecting the bottom line.
Net Profit for the quarter ended March 31, 2026, was ₹342 Crores, a 7% increase compared to the same quarter last year. This growth in Net Profit, while positive, was outpaced by the rise in Tax Expense, which saw a significant 46% year-over-year increase. Sequentially, Net Profit increased by 14% from ₹301 Crores in the prior quarter, showing strong recent performance.